Robert Staszewski is listed as a director on 10 SEC Form D filings by 1 issuer between Feb 2010 and Dec 2023: MINERVA BIOTECHNOLOGIES Corp (Waltham, MA — biotechnology — 2010–2023; $29.3M reported sold to 79 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Cynthia Bamdad (10 shared filings), Kenneth Kosik (10 shared filings), Kenneth Reed (10 shared filings), James Bridges (8 shared filings), Joseph A. Nathan (8 shared filings) and 5 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Robert. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 court case matching the name, 1 bankruptcy case matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 10 public filings for Robert Staszewski and found 7 differences, 3 worth asking the sponsor about: Bankruptcy case: Robert J. Staszewski and Terry S. Staszewski; Form D filed 1,453 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.